| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:nvec | nasdaq:nvec Shareholders | 13F-HR | 0001713521-22-000002 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | Bridge City Capital, LLC | 1713521 | NVE Corporation | COM | 629445206 | 978 | 17951 | SH | SOLE | 7169 | 0 | 10782 | May 19th, 2022 01:14AM | May 19th, 2022 01:14AM | NVE | Pharmaceuticals & Biotechnology | |||
| nasdaq:nvec | nasdaq:nvec Shareholders | 13F-HR/A | 0001166588-22-000018 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | BNP PARIBAS ARBITRAGE, SA | 1166588 | NVE Corp | Equity | 629445206 | 23259 | 427 | SH | DFND | 1 | 0 | 427 | 0 | May 19th, 2022 01:12AM | May 19th, 2022 01:12AM | NVE | Pharmaceuticals & Biotechnology | ||
| nasdaq:nvec | nasdaq:nvec Shareholders | 13F-HR | 0000884548-22-000002 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | CONNORS INVESTOR SERVICES INC | 884548 | NVE CORP | COM | 629445206 | 319 | 5852 | SH | SOLE | 5852 | 0 | 0 | May 19th, 2022 01:11AM | May 19th, 2022 01:11AM | NVE | Pharmaceuticals & Biotechnology | |||
| nasdaq:nvec | nasdaq:nvec Shareholders | 13F-HR | 0001823608-22-000095 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Amalgamated Financial Corp. | 1823608 | NVE CORPORATION | COM | 629445206 | 42 | 768 | SH | SOLE | 768 | 0 | 0 | May 17th, 2022 01:58AM | May 17th, 2022 01:58AM | NVE | Pharmaceuticals & Biotechnology | |||
| nasdaq:nvec | nasdaq:nvec Shareholders | 13F-HR | 0001803916-22-000005 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Aquatic Capital Management LLC | 1803916 | NVE CORP | COM NEW | 629445206 | 5 | 100 | SH | SOLE | 0 | 0 | 100 | May 17th, 2022 01:58AM | May 17th, 2022 01:58AM | NVE | Pharmaceuticals & Biotechnology | |||
| nasdaq:nvec | nasdaq:nvec Shareholders | 13F-HR | 0001567619-22-010940 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CREDIT SUISSE AG/ | 824468 | NVE Corp | COM NEW | 629445206 | 463 | 8500 | SH | DFND | 6 | 8500 | 0 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | NVE | Pharmaceuticals & Biotechnology | ||
| nasdaq:nvec | nasdaq:nvec Shareholders | 13F-HR | 0001567619-22-010940 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CREDIT SUISSE AG/ | 824468 | NVE Corp | COM NEW | 629445206 | 0 | 3 | SH | DFND | 4 | 3 | 0 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | NVE | Pharmaceuticals & Biotechnology | ||
| nasdaq:nvec | nasdaq:nvec Shareholders | 13F-HR | 0001567619-22-010940 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CREDIT SUISSE AG/ | 824468 | NVE Corp | COM NEW | 629445206 | 6 | 108 | SH | DFND | 13 | 108 | 0 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | NVE | Pharmaceuticals & Biotechnology | ||
| nasdaq:nvec | nasdaq:nvec Shareholders | 13F-HR | 0001567619-22-010940 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | CREDIT SUISSE AG/ | 824468 | NVE Corp | COM NEW | 629445206 | 0 | 1 | SH | DFND | 12 | 1 | 0 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | NVE | Pharmaceuticals & Biotechnology | ||
| nasdaq:nvec | nasdaq:nvec Shareholders | 13F-HR | 0001567619-22-010852 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | ROYAL BANK OF CANADA | 1000275 | NVE CORP | COM NEW | 629445206 | 16 | 293 | SH | SOLE | 293 | 0 | 0 | May 17th, 2022 01:55AM | May 17th, 2022 01:55AM | NVE | Pharmaceuticals & Biotechnology |